Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Utilization management in the blood transfusion service.

Literature DB >> 24080431

Utilization management in the blood transfusion service.

Jeremy Ryan Andrew Peña¹, Walter Sunny Dzik.

Abstract

The scope of activity of the Blood Transfusion Service (BTS) makes it unique among the clinical laboratories. The combination of therapeutic and diagnostic roles necessitates a multi-faceted approach to utilization management in the BTS. We present our experience in utilization management in large academic medical center.

Entities: Chemical Disease Gene Species

Keywords: BTS; Blood Transfusion Service; Blood transfusion; CMV; FFP; FNH; IVIg; LR; PCC; PLT; POC; RCT; Transfusion medicine; Utilization management; cytomegalovirus; febrile non-hemolytic; fresh-frozen plasma; intravenous immunoglobulin; leukoreduction/leukoreduced; pRBC; packed red blood cell; platelets; point-of-care; prothrombin complex concentrate; rVIIa; randomized control trial; recombinant activated factor VII

Mesh：

Year: 2013 PMID： 24080431 PMCID： PMC4403789 DOI： 10.1016/j.cca.2013.09.030

Source DB: PubMed Journal: Clin Chim Acta ISSN： 0009-8981 Impact factor: 3.786

36 in total

Review 1. The cytomegalovirus-"safe" blood product: is leukoreduction equivalent to antibody screening?

Authors: J K Preiksaitis
Journal: Transfus Med Rev Date: 2000-04

2. Liberal or restrictive transfusion in high-risk patients after hip surgery.

Authors: Jeffrey L Carson; Michael L Terrin; Helaine Noveck; David W Sanders; Bernard R Chaitman; George G Rhoads; George Nemo; Karen Dragert; Lauren Beaupre; Kevin Hildebrand; William Macaulay; Courtland Lewis; Donald Richard Cook; Gwendolyn Dobbin; Khwaja J Zakriya; Fred S Apple; Rebecca A Horney; Jay Magaziner
Journal: N Engl J Med Date: 2011-12-14 Impact factor: 91.245

3. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness.

Authors: Matthew D Seftel; Gershon H Growe; Tanya Petraszko; W Barrett Benny; Alan Le; Chao-Yong Lee; John J Spinelli; Heather J Sutherland; Peter Tsang; Donna E Hogge
Journal: Blood Date: 2003-09-04 Impact factor: 22.113

4. Effects of storage on the biology and clinical efficacy of the banked red blood cell.

Authors: Christopher P Stowell
Journal: Transfus Apher Sci Date: 2010-06-15 Impact factor: 1.764

5. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.

Authors: Kathryn A O'Connell; Jennifer J Wood; Robert P Wise; Jay N Lozier; M Miles Braun
Journal: JAMA Date: 2006-01-18 Impact factor: 56.272

6. The Age of Blood Evaluation (ABLE) randomized controlled trial: study design.

Authors: Jacques Lacroix; Paul Hébert; Dean Fergusson; Alan Tinmouth; Morris A Blajchman; Jeannie Callum; Deborah Cook; John C Marshall; Lauralyn McIntyre; Alexis F Turgeon
Journal: Transfus Med Rev Date: 2011-05-06

Review 7. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion.

Authors: Arash Afshari; Anne Wikkelsø; Jesper Brok; Ann Merete Møller; Jørn Wetterslev
Journal: Cochrane Database Syst Rev Date: 2011-03-16

8. Variation in use of blood transfusion in coronary artery bypass graft surgery.

Authors: Elliott Bennett-Guerrero; Yue Zhao; Sean M O'Brien; T B Ferguson; Eric D Peterson; James S Gammie; Howard K Song
Journal: JAMA Date: 2010-10-13 Impact factor: 56.272

9. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial.

Authors: Dean A Fergusson; Paul Hébert; Debora L Hogan; Louise LeBel; Nicole Rouvinez-Bouali; John A Smyth; Koravangattu Sankaran; Alan Tinmouth; Morris A Blajchman; Lajos Kovacs; Christian Lachance; Shoo Lee; C Robin Walker; Brian Hutton; Robin Ducharme; Katelyn Balchin; Tim Ramsay; Jason C Ford; Ashok Kakadekar; Kuppuchipalayam Ramesh; Stan Shapiro
Journal: JAMA Date: 2012-10-10 Impact factor: 56.272

Utilization management in the blood transfusion service.

Review 1. The cytomegalovirus-"safe" blood product: is leukoreduction equivalent to antibody screening?

2. Liberal or restrictive transfusion in high-risk patients after hip surgery.

3. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness.

4. Effects of storage on the biology and clinical efficacy of the banked red blood cell.

5. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.

6. The Age of Blood Evaluation (ABLE) randomized controlled trial: study design.

Review 7. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion.

8. Variation in use of blood transfusion in coronary artery bypass graft surgery.

9. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial.

10. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs.

1. Forecasting the Amount of Blood Ordered in the Obstetrics and Gynaecology Ward with the Data Mining Approach.

2. Blood Ordering and Transfusion Practices: An Insight Toward Better Utility of Blood Products.

Review 3. Strategies for utilisation management of hospital services: a systematic review of interventions.

4. An Audit of Requests for Fresh Frozen Plasma in a Tertiary Care Center in South India.

5. Pediatric blood transfusion practices at a regional referral hospital in Kenya.